Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice

Bone

Volumn 41, Issue 5, 2007, Pages 820-832

  Zenger, Serhan ^a   Hollberg, Karin ^a   Ljusberg, Jenny ^a   Norgård, Maria ^a   Ek Rylander, Barbro ^a   Kiviranta, Riku ^b   Andersson, Göran ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Bone resorption; Cathepsin K; Osteoclast; Purple acid phosphatase; Tartrate resistant acid phosphatase; Uteroferrin

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN K; CYSTEINE PROTEINASE INHIBITOR; MESSENGER RNA; MONOMER; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; IN VIVO STUDY; METAPHYSIS; NONHUMAN; OSTEOCLAST; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; TRABECULAR BONE; WESTERN BLOTTING;

ACID PHOSPHATASE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATHEPSINS; CHROMATOGRAPHY, LIQUID; DNA PRIMERS; HYDROLYSIS; ISOENZYMES; MICE; MOLECULAR SEQUENCE DATA; OSTEOCLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 35348903857     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.07.010     Document Type: Article

References (51)

1. Al-Shami R., Sorensen E.S., Ek-Rylander B., Andersson G., Carson D.D., and Farach-Carson M.C. Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway. J Cell Biochem 94 (2005) 1218-1233
2. Angel N.Z., Walsh N., Forwood M.R., Ostrowski M.C., Cassady A.I., and Hume D.A. Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J Bone Miner Res 15 (2000) 103-110
3. Barford D., Das A.K., and Egloff M.P. The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 27 (1998) 133-164
4. Blair H.C. How the osteoclast degrades bone. Bioessays 20 (1998) 837-846
5. Bossard M.J., Tomaszek T.A., Thompson S.K., Amegadzie B.Y., Hanning C.R., Jones C., et al. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem 271 (1996) 12517-12524
6. 2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem 271 (1996) 2126-2132
7. Chirgwin J.M., Przybyla A.E., MacDonald R.J., and Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18 (1979) 5294-5299
8. Ek-Rylander B., Barkhem T., Ljusberg J., Ohman L., Andersson K.K., and Andersson G. Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase. Biochem J 321 Pt 2 (1997) 305-311
9. Ek-Rylander B., Bill P., Norgard M., Nilsson S., and Andersson G. Cloning, sequence, and developmental expression of a type 5, tartrate-resistant, acid phosphatase of rat bone. J Biol Chem 266 (1991) 24684-24689
10. Ek-Rylander B., Flores M., Wendel M., Heinegard D., and Andersson G. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 269 (1994) 14853-14856
11. Everts V., Korper W., Hoeben K.A., Jansen I.D., Bromme D., Cleutjens K.B., et al. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res 21 (2006) 1399-1408
12. Everts V., Korper W., Jansen D.C., Steinfort J., Lammerse I., Heera S., et al. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J 13 (1999) 1219-1230
13. Gelb B.D., Shi G.P., Chapman H.A., and Desnick R.J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273 (1996) 1236-1238
14. Gowen M., Lazner F., Dodds R., Kapadia R., Feild J., Tavaria M., et al. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14 (1999) 1654-1663
15. Halleen J.M., Raisanen S., Salo J.J., Reddy S.V., Roodman G.D., Hentunen T.A., et al. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 274 (1999) 22907-22910
16. Hammarstrom L.E., Hanker J.S., and Toverud S.U. Cellular differences in acid phosphatase isoenzymes in bone and teeth. Clin Orthop Relat Res 78 (1971) 151-167
17. Hayman A.R., Dryden A.J., Chambers T.J., and Warburton M.J. Tartrate-resistant acid phosphatase from human osteoclastomas is translated as a single polypeptide. Biochem J 277 Pt 3 (1991) 631-634
18. Hayman A.R., Jones S.J., Boyde A., Foster D., Colledge W.H., Carlton M.B., et al. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122 (1996) 3151-3162
19. Hollberg K., Hultenby K., Hayman A., Cox T., and Andersson G. Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport. Exp Cell Res 279 (2002) 227-238
20. Hollberg K., Nordahl J., Hultenby K., Mengarelli-Widholm S., Andersson G., and Reinholt F.P. Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix-resorbing clasts. J Bone Miner Metab 23 (2005) 441-449
21. Hsu M.H., Wang M., Browning D.D., Mukaida N., and Ye R.D. NF-kappaB activation is required for C5a-induced interleukin-8 gene expression in mononuclear cells. Blood 93 (1999) 3241-3249
22. Hultenby K., Reinholt F.P., Oldberg A., and Heinegard D. Ultrastructural immunolocalization of osteopontin in metaphyseal and cortical bone. Matrix 11 (1991) 206-213
23. Igarashi Y., Lee M.Y., and Matsuzaki S. Heparin column analysis of serum type 5 tartrate-resistant acid phosphatase isoforms. J Chromatogr B Biomed Sci Appl 757 (2001) 269-276
24. Kafienah W., Bromme D., Buttle D.J., Croucher L.J., and Hollander A.P. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 331 Pt 3 (1998) 727-732
25. Kamiya T., Kobayashi Y., Kanaoka K., Nakashima T., Kato Y., Mizuno A., et al. Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts. J Biochem (Tokyo) 123 (1998) 752-759
26. Kiviranta R., Morko J., Alatalo S.L., NicAmhlaoibh R., Risteli J., and Laitala-Leinonen T. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. Bone 36 (2005) 159-172
27. Kiviranta R., Morko J., Uusitalo H., Aro H.T., Vuorio E., and Rantakokko J. Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K. J Bone Miner Res 16 (2001) 1444-1452
28. Lang P., and Andersson G. Differential expression of monomeric and proteolytically processed forms of tartrate-resistant acid phosphatase in rat tissues. Cell Mol Life Sci 62 (2005) 905-918
29. Li C.Y., Jepsen K.J., Majeska R.J., Zhang J., Ni R., Gelb B.D., et al. Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J Bone Miner Res 21 (2006) 865-875
30. Ljusberg J., Ek-Rylander B., and Andersson G. Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases. Biochem J 343 Pt 1 (1999) 63-69
31. Ljusberg J., Wang Y., Lang P., Norgard M., Dodds R., Hultenby K., et al. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J Biol Chem 280 (2005) 28370-28381
32. Matsuo K., Galson D.L., Zhao C., Peng L., Laplace C., Wang K.Z., et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem 279 (2004) 26475-26480
33. Nesbitt S.A., and Horton M.A. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276 (1997) 266-269
34. Nordahl J., Andersson G., and Reinholt F.P. Chondroclasts and osteoclasts in bones of young rats: comparison of ultrastructural and functional features. Calcif Tissue Int 63 (1998) 401-408
35. Perez-Amodio S., Jansen D.C., Schoenmaker T., Vogels I.M., Reinheckel T., Hayman A.R., et al. Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity. Calcif Tissue Int 79 (2006) 245-254
36. Potts W., Bowyer J., Jones H., Tucker D., Freemont A.J., Millest A., et al. Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy. Int J Exp Pathol 85 (2004) 85-96
37. Rantakokko J., Aro H.T., Savontaus M., and Vuorio E. Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett 393 (1996) 307-313
38. Roodman G.D. Cell biology of the osteoclast. Exp Hematol 27 (1999) 1229-1241
39. Saftig P., Hunziker E., Wehmeyer O., Jones S., Boyde A., Rommerskirch W., et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci U S A 95 (1998) 13453-13458
40. Salo J., Lehenkari P., Mulari M., Metsikko K., and Vaananen H.K. Removal of osteoclast bone resorption products by transcytosis. Science 276 (1997) 270-273
41. Sawae Y., Sahara T., and Sasaki T. Osteoclast differentiation at growth plate cartilage-trabecular bone junction in newborn rat femur. J Electron Microsc (Tokyo) 52 (2003) 493-502
42. Shorey S., Heersche J.N., and Manolson M.F. The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula. Bone 35 (2004) 909-917
43. Silver I.A., Murrills R.J., and Etherington D.J. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 175 (1988) 266-276
44. Suter A., Everts V., Boyde A., Jones S.J., Lullmann-Rauch R., Hartmann D., et al. Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp5) revealed by doubly deficient mice. Development 128 (2001) 4899-4910
45. Teitelbaum S.L. Bone resorption by osteoclasts. Science 289 (2000) 1504-1508
46. Vaananen H.K., and Horton M. The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. J Cell Sci 108 Pt 8 (1995) 2729-2732
47. Vaaraniemi J., Halleen J.M., Kaarlonen K., Ylipahkala H., Alatalo S.L., Andersson G., et al. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res 19 (2004) 1432-1440
48. Wang Y., and Andersson G. Expression and proteolytic processing of mammalian purple acid phosphatase in CHO-K1 cells. Arch Biochem Biophys 461 (2007) 85-94
49. Wang Y., Norgard M., and Andersson G. N-glycosylation influences the latency and catalytic properties of mammalian purple acid phosphatase. Arch Biochem Biophys 435 (2005) 147-156
50. Wei S., Teitelbaum S.L., Wang M.W., and Ross F.P. Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors. Endocrinology 142 (2001) 1290-1295
51. Xia L., Kilb J., Wex H., Li Z., Lipyansky A., Breuil V., et al. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones. Biol Chem 380 (1999) 679-687